Related Experiment Video
Updated: Jun 1, 2026
07:15
Robust Ligature-Induced Model of Murine Periodontitis for the Evaluation of Oral Neutrophils
Published on: January 21, 2020
Alpha-1-antitrypsin deficiency and periodontitis, a pilot study.
Viveca Wallin-Bengtsson1, Eeva Piitulainen, Kristina Hamberg
1Periodontology, Public Dental Health Sciences, Kristianstad, Sweden.
Swedish Dental Journal
|May 20, 2011
Summary
Alpha-1-antitrypsin deficiency (AATD) did not alter periodontal health or GCF elastase levels. This study found no significant differences in periodontal parameters or elastase in gingival crevicular fluid (GCF) between AATD and normal AAT individuals.
Area of Science:
- Periodontology
- Pulmonology
- Genetics
Background:
- Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder that increases the risk of lung and liver diseases.
- The role of AATD in periodontal disease pathogenesis is not well understood.
- Gingival crevicular fluid (GCF) contains proteins like alpha-1-antitrypsin (AAT) and elastase, which may be relevant to periodontal health.
Purpose of the Study:
- To compare periodontal parameters and elastase levels in GCF between individuals with severe AATD (phenotype PiZZ) and healthy controls (phenotype PiMM).
- To investigate potential differences in GCF elastase activity in AATD subjects with and without chronic obstructive pulmonary disease (COPD).
Main Methods:
- The study included 30 subjects: 20 with severe AATD (10 with COPD, 10 asymptomatic) and 10 controls.
- Periodontal examination included Gingival Index (GI), Plaque Index (PlI), probing pocket depth (PPD), and radiography.
- GCF was collected for analysis of AAT concentration, elastase activity, and total protein content.
Main Results:
- No statistically significant differences were observed in GI, PlI, PPD, or radiographic findings between the groups.
- AAT levels in plasma and GCF were significantly lower in AATD subjects (groups 1 and 2) compared to controls (group 3).
- No significant differences in GCF elastase activity were found among the three groups.
Conclusions:
- Periodontal parameters and GCF elastase levels do not differ between individuals with severe AATD (PiZZ) and those with normal AAT levels (PiMM).
- AATD does not appear to directly influence periodontal inflammation or tissue destruction as measured by these parameters.
- Further research may be needed to explore other potential roles of AATD in oral health.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...